VIB-193

N/A

Report date: 2026/03/19 20:00:18

Base Information

Drug NameVIB-193
Drug Alias NameVIB-193VIB193
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibodyBiologics > T cell engagersSmall molecules > Prodrug
Mechanisms of ActionAnti-Carbonic anhydrase IXCD3 T-cell engagers
TargetsCarbonic anhydrase IXT cell surface glycoprotein CD3
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesVibrant Sciences Ltd
China Registration ClassN/A

Develop Information

Active CompaniesVibrant Sciences Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A